Comparison of the Efficacy of Budesonide Nebulizer Suspension and Budesonide Inhalation Suspension in the Treatment of Acute Exacerbation of Chronic Obstructive Pulmonary Disease

Q: How can I download an article?

To download an article from SID, first log in to the site, search for the article title, and click on the 'Download Article' option.

Q: How can I download an ISI article?

To download an ISI article on SID, enter the keyword or article title in the search bar, view the relevant results, click on the desired article, and select the 'Download Article' option.

Q: How can I access the SID database?

To access the SID database, visit SID.ir, create an account, and log in to access scientific resources.

Q: Is downloading articles from SID free?

Some articles on SID are available for free, while others require payment. Details are specified on the article's page.

EMAMI ARDESTANI MOHAMMAD; Klantar Elham; Azimian Mahdi

مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Journal Paper

Paper Information

Journal: TANAFFOS Year:2018 | Volume:17 | Issue:2 Page(s): 96-102

Download Full-Text

View:

198

Download:

140

Cites:

Information Journal Paper

Title

Comparison of the Efficacy of Budesonide Nebulizer Suspension and Budesonide Inhalation Suspension in the Treatment of Acute Exacerbation of Chronic Obstructive Pulmonary Disease

Author(s)

EMAMI ARDESTANI MOHAMMAD | Klantar Elham | Azimian Mahdi | Issue Writer Certificate

Keywords

Nebulizer

Turbuhaler

Budesonide

Chronic Obstructive Pulmonary Disease

Abstract

Background: Inhaled corticosteroids have been successfully used to improve lung function. Budesonide Nebulizer suspension and Budesonide inhalation suspension are two inhaled corticosteroids used in treating chronic obstructive pulmonary disorder (COPD). We compared the efficacy of Budesonide Nebulizer suspension and Budesonide inhalation suspension in the treatment of patients with acute exacerbations of COPD, to prioritize the two treatments. Materials and Methods: In our study, 90 patients were recruited and divided randomly into two groups: Budesonide Nebulizer suspension (Pulmicort Nebulizer) and Budesonide inhalation suspension (Pulmicort Turbuhaler) groups. Demographic characteristics, patient clinical information, and paraclinical data including arterial blood gases (ABG) and O2 Saturation were recorded both at the beginning of hospitalization and on the seventh day of treatment. The collected data were analyzed through independent sample t-test, paired sample t-test, chi-square test, and linear regression using SPSS version 20. Results: Our findings revealed that there were no significant differences in O2SAT or ABG between the two groups at baseline or after seven days of treatment (P > 0. 05). After seven days of treatment, mean O2SAT and arterial blood gases had increased significantly in each group (P < 0. 001). Conclusion: This study found no significant difference between the two groups with respect to the method of treatment. Therefore, Turbuhaler can be used at home by patients so, it leads to elimination of costs and hospital stays.

Cites

No record.

References

No record.

Cite

APA: Copy

EMAMI ARDESTANI, MOHAMMAD, Klantar, Elham, & Azimian, Mahdi. (2018). Comparison of the Efficacy of Budesonide Nebulizer Suspension and Budesonide Inhalation Suspension in the Treatment of Acute Exacerbation of Chronic Obstructive Pulmonary Disease. TANAFFOS, 17(2), 96-102. SID. https://sid.ir/paper/718399/en

Vancouver: Copy

EMAMI ARDESTANI MOHAMMAD, Klantar Elham, Azimian Mahdi. Comparison of the Efficacy of Budesonide Nebulizer Suspension and Budesonide Inhalation Suspension in the Treatment of Acute Exacerbation of Chronic Obstructive Pulmonary Disease. TANAFFOS[Internet]. 2018;17(2):96-102. Available from: https://sid.ir/paper/718399/en

IEEE: Copy

MOHAMMAD EMAMI ARDESTANI, Elham Klantar, and Mahdi Azimian, “Comparison of the Efficacy of Budesonide Nebulizer Suspension and Budesonide Inhalation Suspension in the Treatment of Acute Exacerbation of Chronic Obstructive Pulmonary Disease,” TANAFFOS, vol. 17, no. 2, pp. 96–102, 2018, [Online]. Available: https://sid.ir/paper/718399/en

Related Journal Papers

No record.

Related Seminar Papers

No record.

Related Plans

No record.

Recommended Workshops